Impact of smoking cessation on platelet aggregation in clopidogrel-treated patients after PCI

被引：0
作者：
Ramotowski, B. [1 ]
Witowicz, A. [2 ]
Bracha, J. [2 ]
Budaj, A. [1 ]
机构：
[1] Grochowski Hosp, Dept Cardiol, Warsaw, Poland
[2] Grochowski Hosp, Students Sci Grp, Dept Cardiol, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4430
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [41] Current Evidence for Genetic Testing in Clopidogrel-Treated Patients Undergoing Coronary Stenting
    Sibbing, Dirk
    Bernlochner, Isabell
    Kastrati, Adnan
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2011, 4 (05) : 505 - 513
  • [42] Antiplatelet function variability in clopidogrel-treated patients: need for new antiplatelet agents
    Hoechtl, Thomas
    Tentzeris, Iannis
    Schroer, Karsten
    Huber, Kurt
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 (01) : 2 - 10
  • [43] High On-Treatment Platelet Reactivity in Clopidogrel-Treated Patients Undergoing Elective Carotid Stenting: Correlation with Previous Cerebrovascular Events
    Lenti, Massimo
    Conti, Valentina
    De Rango, Paola
    Guglielmini, Giuseppe
    Manzone, Alessandra
    Sebastiano, Manuela
    Falcinelli, Emanuela
    Mezzasoma, Annamaria
    Simonte, Gioele
    Giordano, Giuseppe
    Gresele, Paolo
    CIRCULATION, 2012, 126 (21)
  • [44] Transfusion requirements in clopidogrel-treated coronary artery bypass graft surgery patients.
    Radovancevic, R
    Chen, L
    Riggs, SA
    Nussmeier, NA
    Cooper, JR
    Bracey, AW
    TRANSFUSION, 2002, 42 (09) : 18S - 18S
  • [45] Feasibility of platelet function point-of-care test in ticagrelor or clopidogrel-treated patients undergoing coronary artery bypass graft surgery
    Barrera-Ramirez, C. F.
    Pineda-Pompa, L. R.
    Camacho-Garcia, M. A.
    Carranza-Rebollar, A.
    Uresti-Flores, E.
    Campo-Aguirre, R.
    Tovar-Maldonado, J. A.
    Valdes-Castro, R.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1000 - 1001
  • [46] A double-blind and randomized study on the existence and prevention of a rebound phenomenon of platelet aggregation after cessation of clopidogrel treatment
    Sibbing, D.
    Stegherr, J.
    Mehilli, J.
    Schulz, S.
    Braun, S.
    Graf, I.
    Vogt, W.
    Kastrati, A.
    Von Beckerath, N.
    Schomig, A.
    EUROPEAN HEART JOURNAL, 2009, 30 : 194 - 194
  • [47] Prediction of high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndromes, using advanced artificial neural networks
    Podda, G. M.
    Grossi, E.
    Palmerini, T.
    Buscema, M.
    Femia, E. A.
    Mariani, A.
    Riva, D. D.
    Cattaneo, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 287 - 287
  • [48] Effects of pioglitazone on platelet P2Y12-mediated signalling in clopidogrel-treated patients with type 2 diabetes mellitus
    Suryadevara, Siva
    Ueno, Masafumi
    Tello-Montoliu, Antonio
    Ferreiro, Jose Luis
    Desai, Bhaloo
    Rollini, Fabiana
    Box, Lyndon C.
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    THROMBOSIS AND HAEMOSTASIS, 2012, 108 (05) : 930 - 936
  • [49] Platelet-to-lymphocyte ratio but not neutrophil-to-lymphocyte ratio predicts high on-treatment platelet reactivity in clopidogrel-treated patients with acute coronary syndrome
    Efe, Edem
    Kocayigit, Ibrahim
    Turker, Pabuccu Mustafa
    Murat, Kucukukur
    Erkan, Alpaslan
    Sedat, Tas
    Alper, Cil
    Necati, Aksoy Murat
    Gokhan, Vural Mustafa
    Bahri, Akdeniz
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (04) : 355 - 359
  • [50] Study on Clopidogrel in Inhibition of Platelet Aggregation in Suspected Angina Patients, Treated with a Daily Dose of 75 mg of Clopidogrel for 7 Days
    Khan, Hamzullah
    Jan, Hikmatullah
    Hafizullah, Mohammad
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2009, 8 (02): : 135 - 140
12345